CHECK OUT OUR SEPTEMBER ISSUE

Phase I trials test new therapies for kids' cancer

Although most newly diagnosed children with cancer participate in phase III studies, which test standard treatments against promising alternatives, the phase I and II trials stand to help the 20% or so of children who aren't cured or whose cancer
returns. » More

To MOC or not to MOC?

Readers respond to "Maintenance of Certification: Myths, facts, and FAQs" and raise questions about HIPAA compliance and SurveyMonkey. » More

Living past cancer: Late effects and long-term care

The pediatrician's role in cancer care for children is important first as a diagnostician and then as a watchful monitor of long-term care. » More

Tumor classification using molecular signatures

Classifying malignant tumors has typically relied on pathologic criteria from the tissue site of origin with histologic and other clinical characteristics of the tumor determining the target and type of therapeutic intervention. This approach to classifying cancer, however, is slowly being rethought. » More

More articles in this issue

Pediatric practice and the bottom line

New model emerges for hospital-based pediatric care

Dermcase: Infant's growing birthmark causes blurry vision

Physicians to appeal court's affirmation of Florida law restricting gun counseling

Downloads

You are subscribed to the Contemporary Pediatrics Issue Alert. Unsubscribe here.